High-dose daptomycin is effective as an antibiotic-lock therapy?

0

In this study, we report that a high dose of daptomycin-lock therapy may offer a therapeutic advantage for these CRBSI in just 24 h of treatment” Basas et al (2017).

Abstract:

Long-term catheter-related bloodstream infections (CRBSI) involving coagulase-negative Staphylococci are associated with poor patient outcomes, increased hospitalization and high treatment costs. The use of vancomycin-lock therapy has been an important step forward to treat these biofilms although failures appear in 20% of patients. In this study, we report that a high dose of daptomycin-lock therapy may offer a therapeutic advantage for these CRBSI in just 24 h of treatment.

Reference:

Basas, J., Palau, M., Ratia, C., Luis Del Pozo, J., Martín-Gómez, M.T., Gomis, X., Torrents, E., Almirante, B. and Gavaldà, J. (2017) High-dose daptomycin is effective as an antibiotic-lock therapy in a rabbit model of Staphylococcus epidermidis catheter-related infection. Antimicrobial Agents and Chemotherapy. November 20th. [epub ahead of print].

doi: 10.1128/AAC.01777-17.

Thank you to our partners for supporting IVTEAM

Share.

Comments are closed.

Free Email Updates
Join 5.5K IVTEAM members. Subscribe now and be the first to receive all the latest free updates from IVTEAM!
100% Privacy. We don't spam.